These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2460446)
41. Effect of microbial and mite proteases on low and high molecular weight kininogens. Generation of kinin and inactivation of thiol protease inhibitory activity. Maruo K; Akaike T; Inada Y; Ohkubo I; Ono T; Maeda H J Biol Chem; 1993 Aug; 268(24):17711-5. PubMed ID: 8349656 [TBL] [Abstract][Full Text] [Related]
42. Effect of neurotropin on the binding of high molecular weight kininogen and Hageman factor to human umbilical vein endothelial cells and the autoactivation of bound Hageman factor. Shibayama Y; Reddigari SR; Teruya M; Nakamura K; Fukunaga Y; Ienaga K; Nishikawa K; Suehiro S; Kaplan AP Biochem Pharmacol; 1998 Apr; 55(8):1175-80. PubMed ID: 9719471 [TBL] [Abstract][Full Text] [Related]
43. Structural changes of plasma high molecular weight kininogen after in vitro activation and in sepsis. Schmaier AH; Farber A; Schein R; Sprung C J Lab Clin Med; 1988 Aug; 112(2):182-92. PubMed ID: 2456360 [TBL] [Abstract][Full Text] [Related]
44. High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. Renné T; Dedio J; David G; Müller-Esterl W J Biol Chem; 2000 Oct; 275(43):33688-96. PubMed ID: 10843988 [TBL] [Abstract][Full Text] [Related]
45. High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization. van Iwaarden F; de Groot PG; Sixma JJ; Berrettini M; Bouma BN Blood; 1988 May; 71(5):1268-76. PubMed ID: 3282568 [TBL] [Abstract][Full Text] [Related]
46. Human umbilical vein endothelial cells express high affinity receptors for factor Xa. Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923 [TBL] [Abstract][Full Text] [Related]
47. Endothelial cell VE-cadherin functions as a receptor for the beta15-42 sequence of fibrin. Bach TL; Barsigian C; Yaen CH; Martinez J J Biol Chem; 1998 Nov; 273(46):30719-28. PubMed ID: 9804847 [TBL] [Abstract][Full Text] [Related]
49. Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens. Maier M; Austen KF; Spragg J Proc Natl Acad Sci U S A; 1983 Jul; 80(13):3928-32. PubMed ID: 6575386 [TBL] [Abstract][Full Text] [Related]
50. Binding of plasminogen to cultured human endothelial cells. Hajjar KA; Harpel PC; Jaffe EA; Nachman RL J Biol Chem; 1986 Sep; 261(25):11656-62. PubMed ID: 3745161 [TBL] [Abstract][Full Text] [Related]
51. IFN-gamma and IFN-alpha induce the expression and synthesis of Leu 13 antigen by cultured human endothelial cells. Jaffe EA; Armellino D; Lam G; Cordon-Cardo C; Murray HW; Evans RL J Immunol; 1989 Dec; 143(12):3961-6. PubMed ID: 2512344 [TBL] [Abstract][Full Text] [Related]
52. Interactions between the contact system, neutrophils and fibrinogen. Colman RW Adv Exp Med Biol; 1990; 281():105-20. PubMed ID: 1966352 [TBL] [Abstract][Full Text] [Related]
53. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Herbert JM; Dupuy E; Laplace MC; Zini JM; Bar Shavit R; Tobelem G Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):227-31. PubMed ID: 7945245 [TBL] [Abstract][Full Text] [Related]
54. Quantification of human high molecular weight kininogen by immunoblotting with a monoclonal anti-light chain antibody. Reddigari S; Kaplan AP J Immunol Methods; 1989 Apr; 119(1):19-25. PubMed ID: 2651524 [TBL] [Abstract][Full Text] [Related]
55. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. Calderon TM; Factor SM; Hatcher VB; Berliner JA; Berman JW Lab Invest; 1994 Jun; 70(6):836-49. PubMed ID: 8015288 [TBL] [Abstract][Full Text] [Related]
56. Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Zhao Y; Qiu Q; Mahdi F; Shariat-Madar Z; Røjkjaer R; Schmaier AH Am J Physiol Heart Circ Physiol; 2001 Apr; 280(4):H1821-9. PubMed ID: 11247797 [TBL] [Abstract][Full Text] [Related]
57. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114 [TBL] [Abstract][Full Text] [Related]
58. Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function. Scott CF; Silver LD; Purdon AD; Colman RW J Biol Chem; 1985 Sep; 260(19):10856-63. PubMed ID: 3875612 [TBL] [Abstract][Full Text] [Related]
59. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways. Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205 [TBL] [Abstract][Full Text] [Related]
60. Purification and characterization of kininogens from sheep plasma. Baba SP; Zehra S; Bano B Protein J; 2005 Feb; 24(2):95-102. PubMed ID: 16003951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]